Clinical Trial Update: Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pragmatic trial evaluating metformin to address glucose intolerance or increased BMI in patients with prostate cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: RECRUITING